对于首次COVID-19疫苗增剂剂量的犹:摩洛哥的一项跨部门研究
Fatima Zahra Chellat1, Nassiba Bahra1, Zakia Marsou1
1Sidi Mohamed Ben Abdallah University, Fez, Morocco.
Journal of primary care & community health
|July 17, 2025
概括
大多数摩洛哥人对首次COVID-19强剂量犹不决. 疫苗特定的担忧,背景因素和个人信仰显著推动了这种犹,影响了疫情应对工作.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 由于COVID-19的流行,需要进行广泛的疫苗接种,包括补充剂,以减轻严重的疾病和死亡率.
- 低剂量补充剂的摄入是一个重大挑战,主要归因于疫苗的犹.
- 了解犹的驱动因素对于有效的公共卫生战略至关重要.
研究的目的:
- 调查在摩洛哥一般人群中对第一个COVID-19增剂疫苗的犹因素.
- 在摩洛哥境内确定影响疫苗接受或拒绝的关键决定因素.
主要方法:
- 一项涉及574名参与者的横截面研究在摩洛哥费斯的初级医疗保健中心进行.
- 采用基于世卫组织SAGE框架的结构化问卷收集数据,涵盖社会人口统计学,情境,个人,群体和疫苗特定因素.
- 统计分析包括千二测试和多变量后勤回归来确定犹的重要预测因素.
主要成果:
- 相当大的66.2%的参与者报告说,他们对第一剂COVID-19增剂剂量犹不决.
- 疫苗特定的担忧成为犹的最强预测因素 (AOR=27.6),其次是上下文因素 (AOR=7.8) 和个人/团体决定因素 (AOR=3.0).
- 年龄较小 (<46岁) 和收入较低也与增强剂量犹有关.
结论:
- 摩洛哥对COVID-19增剂剂量的犹是多因素的,主要受到疫苗的具体问题,更广泛的上下文问题以及个人/团体信仰的影响.
- 有针对性的沟通,建立信任的倡议和包容性的公共卫生政策对于克服犹是必不可少的.
- 解决这些已识别的因素对于提高增强剂的吸收和加强国家流行病准备和应对至关重要.
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Cross-reactivity
31.5K
Overview
31.5K
Dose-Response Relationship: Potency and Efficacy
5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K
Bias in Epidemiological Studies
695
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
695
Upper Respiratory Drugs: First and Second-Generation Antihistamines
464
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
464


